Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives.
Blood
; 117(6): 2054-60, 2011 Feb 10.
Article
in En
| MEDLINE
| ID: mdl-21048158
Full text:
1
Database:
MEDLINE
Main subject:
Polysaccharides
/
Antithrombins
/
Antithrombin Proteins
/
Heparin Antagonists
/
Anticoagulants
/
Antidotes
Type of study:
Evaluation_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Blood
Year:
2011
Type:
Article
Affiliation country:
France